Broad-Spectrum Antivirals (e.g., Baloxavir Marboxil - Xofluza)

Type: drug

Status: FDA Approved

Developer: Shionogi & Co., Ltd.

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026